Chronic immune activation and inflammation as the cause of malignancy

Abstract

Several chronic infections known to be associated with malignancy have established oncogenic properties. However the existence of chronic inflammatory conditions that do not have an established infective cause and are associated with the development of tumours strongly suggests that the inflammatory process itself provides the prerequisite environment for the development of malignancy. This environment includes upregulation of mediators of the inflammatory response such as cyclo-oxygenase (COX)-2 leading to the production of inflammatory cytokines and prostaglandins which themselves may suppress cell mediated immune responses and promote angiogenesis. These factors may also impact on cell growth and survival signalling pathways resulting in induction of cell proliferation and inhibition of apoptosis. Furthermore, chronic inflammation may lead to the production of reactive oxygen species and metabolites such as malondialdehyde within the affected cells that may in turn induce DNA damage and mutations and, as a result, be carcinogenic. Here it is proposed that the conditions provided by a chronic inflammatory environment are so essential for the progression of the neoplastic process that therapeutic intervention aimed at inhibiting inflammation, reducing angiogenesis and stimulating cell mediated immune responses may have a major role in reducing the incidence of common cancers.

References 152

1. 1.

   Akre K., Ekström A. M., Signorello L. B., Hansson L. E., Nyrén O. Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br J Cancer. 2001;84(7):965-968.

   Not in our library10.1054/bjoc.2001.1702

2. 2.

   Athar M., An K. P., Morel K. D., Kim A. L., Aszterbaum M., Longley J., Epstein E. H., Bickers D. R. Ultraviolet B(UVB)-induced cox-2 expression in murine skin: an immunohistochemical study. Biochem Biophys Res Commun. 2001;280(4):1042-1047.

   Not in our library10.1006/bbrc.2000.4201

3. 3.

   Badawi A. F., Mostafa M. H., Probert A., O'Connor P. J. Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev. 1995;4(1):45-59.

   Not in our library10.1097/00008469-199502000-00004

4. 4.

   Bergers G., Javaherian K., Lo K. M., Folkman J., Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 1999;284(5415):808-812.

   Not in our library10.1126/science.284.5415.808

5. 5.

   Bielefeldt-Ohmann H., Jarnicki A. G., Fitzpatrick D. R. Molecular pathobiology and immunology of malignant mesothelioma. J Pathol. 1996;178(4):369-378.

   Not in our library10.1002/(sici)1096-9896(199604)178:4<369::aid-path460>3.0.co;2-8

6. 6.

   Bonnet M., Guinebretiere J. M., Kremmer E., Grunewald V., Benhamou E., Contesso G., Joab I. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst. 1999;91(16):1376-1381.

   Not in our library10.1093/jnci/91.16.1376

7. 7.

   Bontkes H. J., de Gruijl T. D., Bijl A., Verheijen R. H., Meijer C. J., Scheper R. J., Stern P. L., Burns J. E., Maitland N. J., Walboomers J. M. Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia. J Gen Virol. 1999;80(Pt 9):2453-2459.

   Not in our library10.1099/0022-1317-80-9-2453

8. 8.

   Bontkes H. J., de Gruijl T. D., Walboomers J. M., Schiller J. T., Dillner J., Helmerhorst T. J., Verheijen R. H., Scheper R. J., Meijer C. J. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16. J Gen Virol. 1999;80(Pt 2):409-417.

   Not in our library10.1099/0022-1317-80-2-409

9. 9.
   Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-κB activation · 1999

   Not checked
10. 10.

    Carbone M., Rizzo P., Grimley P. M., Procopio A., Mew D. J., Shridhar V., de Bartolomeis A., Esposito V., Giuliano M. T., Steinberg S. M. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med. 1997;3(8):908-912.

    Not in our library10.1038/nm0897-908

11. 11.

    Cardone M. H., Roy N., Stennicke H. R., Salvesen G. S., Franke T. F., Stanbridge E., Frisch S., Reed J. C. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998;282(5392):1318-1321.

    Not in our library10.1126/science.282.5392.1318

12. 12.
    Non-steroidal anti-inflammatory drugs and bladder cancer prevention · 2000

    No notice
13. 13.

    Cerqueira E. M., Santoro C. L., Donozo N. F., Freitas B. A., Pereira C. A., Bevilacqua R. G., Machado-Santelli G. M. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation? Acta Cytol. 1998;42(3):639-649.

    Not in our library10.1159/000331820

14. 14.

    Clavel C., Masure M., Levert M., Putaud I., Mangeonjean C., Lorenzato M., Nazeyrollas P., Gabriel R., Quereux C., Birembaut P. Human papillomavirus detection by the hybrid capture II assay: a reliable test to select women with normal cervical smears at risk for developing cervical lesions. Diagn Mol Pathol. 2000;9(3):145-150.

    Not in our library10.1097/00019606-200009000-00004

15. 15.

    Clerici M., Shearer G. M. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today. 1994;15(12):575-581.

    Not in our library10.1016/0167-5699(94)90220-8

16. 16.

    Coffey D. S. Self-organization, complexity and chaos: the new biology for medicine. Nat Med. 1998;4(8):882-885.

    Not in our library10.1038/nm0898-882

17. 17.

    Cordon-Cardo C., Prives C. At the crossroads of inflammation and tumorigenesis. J Exp Med. 1999;190(10):1367-1370.

    Not in our library10.1084/jem.190.10.1367

18. 18.

    Cox G., Jones J. L., O'Byrne K. J. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer. Clin Cancer Res. 2000;6(6):2349-2355.

    Not in our library

19. 19.

    Dalgleish A. G. The pathogenesis of AIDS: classical and alternative views. J R Coll Physicians Lond. 1992;26(2):152-158.

    Not in our library

20. 20.

    Dalgleish A. G. Viruses and cancer. Br Med Bull. 1991;47(1):21-46.

    Not in our library10.1093/oxfordjournals.bmb.a072457

21. 21.

    Dalgleish A. The relevance of non-linear mathematics (chaos theory) to the treatment of cancer, the role of the immune response and the potential for vaccines. QJM. 1999;92(6):347-359.

    Not in our library10.1093/qjmed/92.6.347

22. 22.

    Dameron K. M., Volpert O. V., Tainsky M. A., Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 1994;265(5178):1582-1584.

    Not in our library10.1126/science.7521539

23. 23.

    De Luca A., Baldi A., Esposito V., Howard C. M., Bagella L., Rizzo P., Caputi M., Pass H. I., Giordano G. G., Baldi F. The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas. Nat Med. 1997;3(8):913-916.

    Not in our library10.1038/nm0897-913

24. 24.

    De Marzo A. M., Coffey D. S., Nelson W. G. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology. 1999;53(3 Suppl 3A):29-42.

    Not in our library10.1016/s0090-4295(98)00536-6

25. 25.

    Della Bella S., Molteni M., Compasso S., Zulian C., Vanoli M., Scorza R. Differential effects of cyclo-oxygenase pathway metabolites on cytokine production by T lymphocytes. Prostaglandins Leukot Essent Fatty Acids. 1997;56(3):177-184.

    Not in our library10.1016/s0952-3278(97)90531-7

26. 26.

    Di Popolo A., Memoli A., Apicella A., Tuccillo C., di Palma A., Ricchi P., Acquaviva A. M., Zarrilli R. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells. Oncogene. 2000;19(48):5517-5524.

    Not in our library10.1038/sj.onc.1203952

27. 27.

    Doherty P. C., Tripp R. A., Sixbey J. W. Evasion of host immune responses by tumours and viruses. Ciba Found Symp. 1994;187:245-260.

    Not in our library10.1002/9780470514672.ch16

28. 28.

    Dubois R. N., Abramson S. B., Crofford L., Gupta R. A., Simon L. S., Van De Putte L. B., Lipsky P. E. Cyclooxygenase in biology and disease. FASEB J. 1998;12(12):1063-1073.

    Not in our library

29. 29.

    Dumas F., Eschwège P., Loric S. Acute bacterial prostatitis induces hematogenous dissemination of prostate epithelial cells. Clin Chem. 1997;43(10):2007-2008.

    Not in our library

30. 30.

    Duperron C., Castonguay A. Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis. 1997;18(5):1001-1006.

    Not in our library10.1093/carcin/18.5.1001

31. 31.

    Edwards J. G., Abrams K. R., Leverment J. N., Spyt T. J., Waller D. A., O'Byrne K. J. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax. 2000;55(9):731-735.

    Not in our library10.1136/thorax.55.9.731

32. 32.

    El-Bayoumy K., Iatropoulos M., Amin S., Hoffmann D., Wynder E. L. Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3-pyridyl)-1-butanone: the impact of a high-fat diet. Cancer Res. 1999;59(7):1400-1403.

    Not in our library

33. 33.

    Eliopoulos A. G., Gallagher N. J., Blake S. M., Dawson C. W., Young L. S. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. J Biol Chem. 1999;274(23):16085-16096.

    Not in our library10.1074/jbc.274.23.16085

34. 34.

    Faux S. P., Houghton C. E., Hubbard A., Patrick G. Increased expression of epidermal growth factor receptor in rat pleural mesothelial cells correlates with carcinogenicity of mineral fibres. Carcinogenesis. 2000;21(12):2275-2280.

    Not in our library10.1093/carcin/21.12.2275

35. 35.

    Faux S. P., Howden P. J. Possible role of lipid peroxidation in the induction of NF-kappa B and AP-1 in RFL-6 cells by crocidolite asbestos: evidence following protection by vitamin E. Environ Health Perspect. 1997;105(Suppl 5):1127-1130.

    Not in our library10.1289/ehp.97105s51127

36. 36.

    Fleming S. Renal cancer genetics: von Hippel Lindau and other syndromes. Int J Dev Biol. 1999;43(5):469-471.

    Not in our library

37. 37.

    Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med. 1995;333(26):1757-1763.

    Not in our library10.1056/nejm199512283332608

38. 38.

    Funkhouser E. M., Sharp G. B. Aspirin and reduced risk of esophageal carcinoma. Cancer. 1995;76(7):1116-1119.

    Not in our library10.1002/1097-0142(19951001)76:7<1116::aid-cncr2820760703>3.0.co;2-i

39. 39.

    Gabrilovich D. I., Ishida T., Nadaf S., Ohm J. E., Carbone D. P. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function. Clin Cancer Res. 1999;5(10):2963-2970.

    Not in our library

40. 40.

    Gallucci R. M., Simeonova P. P., Matheson J. M., Kommineni C., Guriel J. L., Sugawara T., Luster M. I. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J. 2000;14(15):2525-2531.

    Not in our library10.1096/fj.00-0073com

Cited by papers we hold 6

• Deletion of interleukin-6 in monocytes/macrophages suppresses the initiation of hepatocellular carcinoma in mice · 2016
  No notice
• The wound inflammatory response exacerbates growth of pre‐neoplastic cells and progression to cancer · 2015
  No notice
• The Potential Benefits of Red Beetroot Supplementation in Health and Disease · 2015
  No notice
• The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC. · 2011
  Not checked
• Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses · 2009
  No notice
• The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer · 2005
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.